Markets:

Overview

News

Currencies

International

Treasuries

Corvus Pharmaceuticals, Inc. - Common Stock (NQ:CRVS)

18.66 -0.10 (-0.53%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Corvus Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Dow Surges 150 Points, US Current Account Deficit Widens In Q3 ↗

December 18, 2024

Via Benzinga

Topics Stocks

Heico, Corvus Pharmaceuticals, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

December 18, 2024

Via Benzinga

US Stocks To Open Higher As Rate Cut Expectations Surge: All Eyes On Dow Jones To Break Its 9-Day Losing Streak ↗

December 18, 2024

U.S. stock futures climbed on Wednesday as Wall Street awaits the Fed's final interest rate decision and its monetary policy forecasts for 2025.

Via Benzinga

Topics Economy Stocks

Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket ↗

December 18, 2024

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

An Overview of Corvus Pharma's Earnings ↗

November 11, 2024

Via Benzinga

Earnings Outlook For Corvus Pharma ↗

March 18, 2024

Via Benzinga

Preview: Corvus Pharma's Earnings ↗

November 06, 2023

Via Benzinga

Stellantis, MicroStrategy, Bit Digital And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

September 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 30, 2024

Via Benzinga

Why Nio Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

September 30, 2024

Via Benzinga

Casella Waste Systems, SES AI And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

September 18, 2024

Via Benzinga

Topics Artificial Intelligence

The Latest Analyst Ratings for Corvus Pharma ↗

June 16, 2023

Via Benzinga

Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday ↗

September 16, 2024

Via Benzinga

Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

August 07, 2024

Via Benzinga

The 2024 Millionaire’s Club: 3 Penny Stocks to Buy Now ↗

May 31, 2024

One of the best ways to spot opportunity in penny stocks to buy is by following insiders. Here are three to consider.

Via InvestorPlace

CRVS Stock Earnings: Corvus Pharma Misses EPS for Q1 2024 ↗

May 06, 2024

CRVS stock results show that Corvus Pharma missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 09, 2024

Via Benzinga

CRVS Stock Earnings: Corvus Pharma Misses EPS for Q4 2023 ↗

March 19, 2024

CRVS stock results show that Corvus Pharma missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Earnings Scheduled For March 19, 2024 ↗

March 19, 2024

Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per share on revenue of $931.97 million.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 09, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 08, 2024

Via Benzinga

Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket ↗

December 11, 2023

Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Green Giant shares dipped 37.1% to $0.1599 in pre-market trading. Here are some...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 06, 2023

Via Benzinga

Corvus Pharmaceuticals Eyes Expansion Of Blood Cancer Therapy but Resource Limitations Pose Challenge: Oppenheimer ↗

August 18, 2023

Oppenheimer has initiated coverage on Corvus Pharmaceuticals Inc (NASDAQ: CRVS) with an Outperform rating and a

Via Benzinga

Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

September 07, 2023

Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 100% to $1.7909 after the company's subsidiary Champion Safe has been bombarded with calls from safe dealers and customers looking for...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 15, 2023

Via Benzinga

Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 10, 2023

Gainers Mobilicom Limited (NASDAQ: MOB) shares jumped 81.3% to $2.7187 after the company announced it received a commercial scale purchase order from Teledyne-FLIR for the production of drones for the...

Via Benzinga

Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 15, 2023

Gainers SCWorx Corp. (NASDAQ: WORX) shares jumped 281% to $0.8396.

Via Benzinga

Biotech Alert: Searches Spiking For These Stocks Today - Friday, June 2 ↗

June 02, 2023

Various names in the biotech sector are seeing a substantial increase in search activity today. Such names include the likes of Akebia Therapeautics, Corvus Pharmaceuticals, and Mirati Therapeutics.

Via Talk Markets

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Corvus Pharmaceuticals, Inc. - Common Stock (NQ:CRVS)

Headline News about Corvus Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today